Tetra Bio-Pharma Inc. is pleased to provide investors with an update on our research, regulatory and commercial activities after closing the public placement.
Tetra Bio-Pharma Inc. is pleased to announce it has closed its previously announced short form prospectus offering of units of the Corporation, including the exercise in full of the Agents’ over-allotment option.
Panag Pharma Receives a Repayable $500,000 Contribution from the Atlantic Canada Opportunities Agency (ACOA)
Tetra Bio-Pharma Inc. is pleased to announce that its wholly owned subsidiary Panag Pharma Inc. has received a repayable Government of Canada contribution of $500,000 through the Atlantic Canada Opportunities Agency’s (ACOA) Business Development Program.
Carol Levine (Energi PR)
Tel: 514.288.8500, ext. 226